|
Placebo (n=120) |
Selenium (n=117) |
P value* |
| Age(Mean) |
59.4 ± 11.3 years |
58.9 ± 11.2 years |
0.70 |
Sex
Male
Female |
63 (52.5%)
57 (47.5%) |
79 (68.7%)
36 (31.3%) |
0.01 |
Risk Factors
Smoking
Hypertension
Dyslipidemia
Diabetes
Family history |
72 (60%)
60 (50%)
35 (29.2%)
36 (30%)
11 (9.2%) |
83(71%)
43 (36.8%)
32 (27.4%)
35 (29.9%)
13 (11.1%) |
0.30
0.05
0.75
0.99
0.62 |
| Body mass index (mean) |
26.5 ± 3.7 |
26.9 ± 4.5 |
0.50 |
Left ventricular function
Ejection fraction ≥ 50%
Ejection fraction< 50% |
75 (62.5%)
45 (37.5%) |
73 (62.4%)
44 (37.6%) |
0.90 |
| Anemia |
32 (26.7%) |
22 (18.8%) |
0.16 |
| Hyperglycemia on admission |
30 (25%) |
17 (14.5%) |
0.07 |
| Baseline creatinine (mg/dl) |
1.01 ± 0.3 |
0.98 ± 0.25 |
0.42 |
| Contrast volume (cc) |
175 ± 115 |
185 ± 110 |
0.35 |
| Type of procedure |
CAG: 52 (43.3%)
PCI: 69 (56.7%) |
CAG: 42 (35.9%)
PCI: 75 (64.1%) |
0.24 |
